For the impacts of TET1 on MASLD progression, it has been suggested that depleting adipocyte TET1 protects mice from MASLD through suppressing obesity and insulin resistance (Damal Villivalam et al, 2020). This evidence concerns the gene TET1 and metabolic dysfunction-associated steatotic liver disease.